Nasopharyngeal (nay-zoh-fuh-RIN-jee-ul) carcinoma igomarara rinoitika mu nasopharynx, iri kuseri kwemhino yako nepamusoro pehuro yako.
Nasopharyngeal carcinoma haiwanzo kuwanikwa muUnited States.Zvinoitika kakawanda kune dzimwe nzvimbo dzepasi - kunyanya Southeast Asia.
Nasopharyngeal carcinoma yakaoma kuona nekukurumidza.Zvichida imhaka yekuti nasopharynx haisi nyore kuongorora uye zviratidzo zvenasopharyngeal carcinoma zvinotevedzera zvezvimwe, zvinowanzoitika.
Nasopharyngeal carcinoma inowanzoitika muzera repakati uye vanhu vakuru vanopfuura makore makumi mana, uye ine hunhu hwakajeka hwedunhu uye hwemhuri, uye chiyero chechiitiko muGuangdong chinotanga muChina, inozivikanwawo se "Guangdong cancer".
1.Nhungamiro yeKuongororwa uye Kurapa kweNasopharyngeal carcinoma
Mune 2021 Mirayiridzo yeDiagnostic uye Kurapwa kweNasopharyngeal Carcinoma, iyo Chinese Society of Clinical Oncology (CSCO) yaisanganisira nzira dzekuona serological muKirasi I humbowo hwekuongororwa kwenasopharyngeal carcinoma, uye yakaratidza kuti kusanganiswa kweEB-VCA-IgA. uye EB-NA1-IgA EB-virusi antibodies inogona kuwedzera kukurumidza kuongororwa kwehuwandu hwenasopharyngeal carcinoma nekatatu (21% ~ 79%) uye kuderedza ngozi yekufa ne88%!Iyo 2019 Nyanzvi Consensus paClinical Application yeMarkers yeNasopharyngeal Carcinoma yakataurawo kuti EBV-EA-IgA chiratidzo chechangobva kuitika EBV kutapukira kana kushingaira kupararira kweEBV, ine dhigirii repamusoro, uye inowanzoshandiswa pakuongorora kenza yenasopharyngeal. uye kukurumidza kuongororwa.
Chidzidzo ichi chinoratidza kuti zvitatu zvakasanganiswa zvakaonekwa zveEBV-VCA-IGA, EBV-EA-IGA uye EB-NA1-IgA inovhara zvizere EBV gene spectrum, iyo inovandudza zvinobudirira kunzwisiswa uye kujeka kwekuonekwa kwenasopharyngeal carcinoma, inoderedza kutariswa kwakarasika, kunovimbisa. kurongeka kwekufanotaura kwechirwere, uye inofanotaura kuitika kwechirwere makore 5-10 zvisati zvaitika, izvo zvakakodzera kune yakakura-yepamusoro-soro kenza ye nasopharyngeal.
2.VCA-IgA+EA-IgA+NA1-IgA inogadzirwa neBeijing Beier inogona kupa chirwere chepakutanga chekuongorora cheNasopharyngeal Carcinoma.
Magnetism particulate immuno chemistry luminescence nzira
| Product Name | Kudimburira |
| EB hutachiona VCA-IgA antibody yekuona kit | EB-VCA-IgA |
| EB hutachiona EA-IgA antibody yekuona kit | EB-EA-IgA |
| EB hutachiona NA1-IgA antibody yekuona kit | EB-NA1-IgA |
Elisa Method:
| Product Name | Kudimburira |
| EB hutachiona VCA-IgA Elisa kit | EB-VCA-IgA |
| EB hutachiona EA-IgA Elisa kit | EB-EA-IgA |
| EB hutachiona NA1-IgA Elisa kit | EB-NA1-IgA |
3.Product Performance
Iyo VCA-IgA test kit inogadzirwa neBeijing Beier inogona kutsiva EU yakajairwa kit yekukurumidza kuonekwa uye kuongororwa nasopharyngeal carcinoma.
The British Medical Journal (BMJ) (impact factor 16.378) ndeimwe yezvinyorwa zvina zvinotungamirira zvezvokurapa pasi rose.Muna 2017, boka rekutsvagisa rakaburitsa bepa muBritish Medical Journal (BMJ) "Ongororo yezvinomwe zvinomwe zveVCA-IgA ELISA kits yekuongororwa kwenasopharyngeal carcinoma muChina: muyedzo wekutonga".
Mupepa iri, varwere ve200 vane nasopharyngeal carcinoma (NPC) uye mazana maviri evanhu serum samples (SYSUCC) kubva kuSun Yat-sen University Cancer Center vakadzidza uye vakaedzwa, uye kushanda kweEB-VCA-IgA (ELISA) kits yakagadzirwa ne8. vagadziri vemhando mumusika wepamba vakafananidzwa kuongororwa kwekuita.Mhedziso ndeyokuti EBV-VCA-IgA (ELISA) kit yakagadzirwa neBeijing Beier ine maitiro akafanana ekuongorora maitiro seEBV-VCA-IgA (ELISA) inogadzirwa neagent reagent Oumeng, uye EBV-VCA-IgA (ELISA) kit inogadzirwa neBeijing Beier inogona kutsiva iyo inotengeswa kunze kwenyika kuti itarise nekukurumidza uye kuongororwa kwenasopharyngeal carcinoma.Ruzivo rwevagadziri vemhando vanotora chikamu muyedzo inoratidzwa muTable 1, mhinduro dzebvunzo dzinoratidzwa muTable 2, uye mhedzisiro yebvunzo inoratidzwa muTafura 3.
Test Mhedziso
Zvitatu zvinosanganiswa zvakare VCA-IgA kits-BB,HA neKSB- zvine mhedzisiro yekuongorora yakaenzana neiyo yekit yakajairwa.Inogona kutsiviwa nekit yakajairwa uye misanganiswa yadzo inogona kushandiswa mukuonekwa kwekutanga nekuongorora kweNPC.
Nguva yekutumira: Feb-23-2023